DE69119591D1 - Das von mca-28a32 erkannte antigen - Google Patents

Das von mca-28a32 erkannte antigen

Info

Publication number
DE69119591D1
DE69119591D1 DE69119591T DE69119591T DE69119591D1 DE 69119591 D1 DE69119591 D1 DE 69119591D1 DE 69119591 T DE69119591 T DE 69119591T DE 69119591 T DE69119591 T DE 69119591T DE 69119591 D1 DE69119591 D1 DE 69119591D1
Authority
DE
Germany
Prior art keywords
epitope
mca
antique
detected
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69119591T
Other languages
English (en)
Other versions
DE69119591T2 (de
Inventor
Nicholas Pomato
Ebo Sybren Bos
Janet Hazel Ransom
Michael George Hanna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE69119591D1 publication Critical patent/DE69119591D1/de
Publication of DE69119591T2 publication Critical patent/DE69119591T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
DE69119591T 1990-04-12 1991-04-10 Das von mca-28a32 erkannte antigen Expired - Fee Related DE69119591T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50837390A 1990-04-12 1990-04-12
PCT/US1991/002459 WO1991016629A1 (en) 1990-04-12 1991-04-10 Ctaa 28a32, the antigen recognized by mca 28a32

Publications (2)

Publication Number Publication Date
DE69119591D1 true DE69119591D1 (de) 1996-06-20
DE69119591T2 DE69119591T2 (de) 1996-09-12

Family

ID=24022500

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69119591T Expired - Fee Related DE69119591T2 (de) 1990-04-12 1991-04-10 Das von mca-28a32 erkannte antigen

Country Status (12)

Country Link
EP (1) EP0537168B1 (de)
JP (1) JPH05507470A (de)
KR (1) KR100206061B1 (de)
AT (1) ATE138200T1 (de)
AU (1) AU660927B2 (de)
CA (1) CA2079601A1 (de)
DE (1) DE69119591T2 (de)
DK (1) DK0537168T3 (de)
ES (1) ES2090331T3 (de)
FI (1) FI924576A (de)
GR (1) GR3020387T3 (de)
WO (1) WO1991016629A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69227380T3 (de) * 1991-11-12 2007-01-11 Prana Biotechnology Ltd., South Melbourne Verfahren zur bestimmung und behandlung von alzheimer-krankheit
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6387697B1 (en) 1998-12-28 2002-05-14 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use
AU1807401A (en) 1999-11-30 2001-06-12 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
AU2001252945A1 (en) * 2000-03-24 2001-10-08 Corixa Corporation Compositions and methods for therapy and diagnosis of colon cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210867A (en) * 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use
DK172686A (da) * 1985-04-22 1986-10-23 Hybritech Inc Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
DE3855280T2 (de) * 1987-07-02 1996-09-19 Akzo Nv Von mca 16-88 erkanntes antigen

Also Published As

Publication number Publication date
AU7788491A (en) 1991-11-11
KR100206061B1 (ko) 1999-07-01
ES2090331T3 (es) 1996-10-16
GR3020387T3 (en) 1996-09-30
DK0537168T3 (da) 1996-09-02
FI924576A0 (fi) 1992-10-09
WO1991016629A1 (en) 1991-10-31
JPH05507470A (ja) 1993-10-28
CA2079601A1 (en) 1991-10-13
AU660927B2 (en) 1995-07-13
EP0537168A1 (de) 1993-04-21
FI924576A (fi) 1992-10-09
ATE138200T1 (de) 1996-06-15
EP0537168B1 (de) 1996-05-15
DE69119591T2 (de) 1996-09-12
EP0537168A4 (en) 1993-05-05

Similar Documents

Publication Publication Date Title
DE69230545D1 (de) Antikörperderivate
IT1197431B (it) Antigene anti-malarico, procedimento per la sua preparazione e vaccino che lo contiene
OA08485A (fr) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
DE69119591D1 (de) Das von mca-28a32 erkannte antigen
ATE137674T1 (de) Von mca 16-88 erkanntes antigen
AU625171B2 (en) Specific excretion-secretion antigens of toxoplasma gondii, their expression products, processes for obtaining them and their diagnostic and prophylactic uses
CA2294514A1 (en) Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum
DE3585370D1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
NO862097L (no) Monoklonale antistoffer for humane ikke-smaacelle lungekarsinoma.
NO924803L (no) Tumor-relatert monoklonalt antistoff 88bv59
Fritz IMMUNOLOGICAL INVESTIGATIONS WITH MONOCLONAL ANTIBODY SPECIFIC FOR A LEWIS LUNG TUMOR-ASSOCIATED MEMBRANE ANTIGEN.
Cronin Reactivity of antibodies isolated from immune complexes present in malignant effusions.
DE3777196D1 (de) Anti-parathyroid-antikoerper-praeparat.
FI923418A (fi) Monoklonaalinen vasta-aine
PL245361A1 (en) Method of obtaining antibodies specific for antigens isolated from human serum,in particular for the antigen hbs.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee